Clinical Trials Directory

Trials / Completed

CompletedNCT03857776

Open Dialogue About Complementary Alternative Medicine (CAM) Integrated in Conventional Oncology Care

A Phase Two Parallel-group Randomized Controlled Trial Assessing the Efficacy of Open Dialogue About Complementary Alternative Medicine (CAM) Integrated in Conventional Oncology Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Vejle Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this phase two parallel-group randomized controlled trial is to assess the efficacy of open dialogue about CAM integrated in conventional oncology care. The investigators hypothesize that patients in the intervention group participating in a scheduled open dialogue with a nurse specialist about CAM will experience better physical and mental health compared to patients in the control group receiving standard care alone.

Detailed description

Patients randomized to the intervention group will participate in a scheduled open dialogue about CAM with a specialist nurse, who has completed the Fellowship in Integrative Medicine at the University of Arizona. This is a training program for health professionals in empowering individuals and communities to optimize health and well-being through evidence-based, sustainable and integrative approaches. The open dialogue will be based on the fundamentals of person-centered care according to this program and include patient preferences and wishes, reliable information and counselling and advice about the potential risks and benefits of using CAM as an adjunct to conventional oncology care. All dialogue, each lasting approximately 60 minutes, will be conducted by the same nurse as soon as possible and at the latest two weeks after enrolment. According to patient needs and wishes there may be a follow-up dialogue over the telephone or in the Oncology Outpatient Clinic. The potential second dialogue is estimated to last approximately 30 minutes. Participants in the control group will receive standard information including reference to www.KABcancer.dk, which is a website presenting research on CAM, including information about its potential effects and outcomes.

Conditions

Interventions

TypeNameDescription
OTHEROpen dialogue about complementary alternative medicine1-hour dialogue about CAM with a nurse specialist as an Integrated part of conventional oncology care
OTHERStandard careStandard care including referral to a homepage about CAM

Timeline

Start date
2019-04-05
Primary completion
2020-05-24
Completion
2020-05-24
First posted
2019-02-28
Last updated
2021-04-29

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03857776. Inclusion in this directory is not an endorsement.